Dr. Amaria on Genetically Modified TILs in Melanoma
1 Views
administrator
07/03/23
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
-
Category
Show more
Facebook Comments
No comments found